Twin Peaks Wealth Advisors »

Fate Therapeutics shares owned by Twin Peaks Wealth Advisors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Twin Peaks Wealth Advisors from 13F filings

Historical chart of Twin Peaks Wealth Advisors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Twin Peaks Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Twin Peaks Wealth Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $240 200 1.20
2025-06-30 $187 200 0.94

More positions owned by Twin Peaks Wealth Advisors

Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares S&p 500 Value Etf Etf (IVE)
Nvidia Corporation Stock (NVDA)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Ft Vest Laddered Buffer Etf Etf (BUFR)
Meta Platforms Inc Cl A Stock (META)
First Trust Smith Opportunistic Fixed Income Etf Etf (FIXD)
Ishares Msci Eafe Value Etf Etf (EFV)
First Trust Enhanced Short Maturity Etf Etf (FTSM)
Amazon Stock (AMZN)
First Trust Smith Unconstrained Bond Etf Etf (UCON)

View all positions for Twin Peaks Wealth Advisors

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
Acadian Asset Management
Two Sigma Investments
Johnson & Johnson
AQR Capital Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
UBS Group
Goldman Sachs Group
Tang Capital Management

View all funds holding Fate Therapeutics